DermaScan AI offers a remarkably convenient way to screen moles directly from your browser without needing to download a separate application. The process is streamlined: you simply upload a clear, well-lit photo of the mole in question, and the system analyzes it in seconds. What stands out is the transparency regarding how results are calculated. The tool uses the ABCDE rule to assess asymmetry, border irregularity, color variation, diameter, and evolution. It categorizes findings into three risk tiers based on malignant probability, with a higher threshold for low concern to ensure warnings are not missed. Being trained on real dermoscopic images, it provides a meaningful result for actual mole photos. While it does not replace a dermatologist's judgment or offer a certified diagnosis, it effectively flags patterns that might otherwise be overlooked. This makes it an excellent tool for proactive skin health monitoring, allowing users to identify when professional medical attention is warranted based on visual changes in their skin.
Ask AI about DermaScan AI
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
Love how fast it analyzes my mole photo and gives clear risk tiers!
I just tried uploading a photo of a mole on my arm. It was super fast and gave me a clear confidence score. The three-tier system makes it easy to understand if I should worry or just keep an eye on it. It's not a doctor, but it's a quick way to get a second opinion at home before booking an appointment.
The initial interface seems simple enough for quick mole checks, though the reliance on user-uploaded photos means image quality directly impacts the accuracy of the results.
DermaScan AI presents a straightforward approach to mole risk screening by utilizing the ABCDE rule, which dermatologists commonly use to identify warning signs. The interface allows users to upload a clear, well-lit photo of a mole, and the system analyzes patterns in just a few seconds. The model is trained on real dermoscopic images, boasting a ninety-five percent test accuracy rate across three distinct risk tiers. I appreciate that the tool provides specific confidence percentages rather than vague assessments. The logic behind the tiers makes sense: a threshold above sixty percent triggers a recommendation to see a dermatologist, while lower scores indicate low concern. This conservative approach ensures that potential issues are flagged early. However, it is important to remember that this is not a certified medical device and does not constitute a diagnosis. The tool serves best as a preliminary check to help recognize when a mole warrants professional attention. It is a helpful supplementary aid for monitoring skin health, provided users understand its limitations and consult a licensed specialist for definitive answers regarding any concerning changes in their skin.
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About DermaScan AI
DermaScan AI is a browser-based tool that analyzes photos of moles for patterns associated with skin cancer risk. It applies the ABCDE rule used by dermatologists and categorizes results into three risk tiers: low concern, uncertain, or a recommendation to see a dermatologist. The tool reports that its model was trained on more than 260 dermoscopic images and achieved 95% test accuracy, and it processes images locally in the user's browser. It explicitly states that it does not provide a medical diagnosis and that users with concerning results should consult a dermatologist.
- Website
- dermascn.com
- Categories
- Computer software, Biotechnology, Medical practice